Flores PFJ, Boyer DE, Vargas CE, Escobar AE, Montes de Oca OCR, Alfeirán RA

Language: Spanish
References: 14
Page: 274-277
PDF size: 145.20 Kb.

ABSTRACT

The sign of Leser-Trélat is a cutaneous paraneoplastic syndrome; it is an explosive dermatosis (seborrheic keratosis) associated with occult malignancy. Male 67, started with dyspepsia, aerophagia and reflux, weight loss. Physical examination with brown keratotic neoformations, in thorax and abdomen. In the endoscopy was found a gastric adenocarcinoma. PET/CT with liver metastases. Esophagogastrectomy was performed with esophagogastric anastomosis. The pathophysiology is presumed by growth factors produced by the tumor. Survival depends on the type and stage of the primary tumor. When this sign is found, the intentional search for occult neoplasia is recommended.

REFERENCES

1. Safa G, Darrieux L. Leser-Trélat sign without internal malignancy. Case Rep Oncol. 2011; 4 (1): 175-177.

2. Turan E, Yesilova Y, Yurt N, Koçarslan S. Leser-Trélat sign: does it really exist? Acta Dermatovenerol Croat. 2013; 21 (2): 123-127.

3. Venegas AF, Vaccaro MP, Abudinén AG, Reydet VC, Brunie VF, Arcuch DJ. Signo de Leser-Trélat asociado a adenocarcinoma gástrico: Caso clínico. Rev Méd Chile. 2012; 140 (12): 1585-1588.

4. Ponti G, Luppi G, Losi L, Giannetti A, Seidenari S. Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. J Hematol Oncol. 2010; 3: 2.

5. Dasanu CA, Alexandrescu DT. Bilateral Leser-Trélat sign mirroring lung adenocarcinoma with early metastases to the contralateral lung. South Med J. 2009; 102 (2): 216-218.

6. Li JH, Guo H, Li B, Gao XH. Leser-Trelat sign with primary hepatic carcinoma. Indian J Dermatol Venereol Leprol. 2015; 81 (3): 320-321.

7. Blázquez N, Fernández-López E, Fernández-Canedo I, de Unamuno P, Martín-Pascual A. Signo de Leser-Trélat asociado a síndrome de Sézary. Actas Dermosifiliogr. 2009; 94 (5): 309-312.

8. Nyati A, Kalwaniya S, Jain S, Soni B. Sign of Leser-Trélat in association with laryngeal carcinoma. Indian J Dermatol Venereol Leprol. 2016; 82 (1): 112.

9. Sperry K, Wall J. Adenocarcinoma of the stomach with eruptive seborrheic keratoses: the sign of Leserp-Trélat. Cancer. 1980; 45 (9): 2434-2437.

10. Mittal RR, Sonal J. The sign of Leser-Trelat. Indian J Dermatol Venereol Leprol. 2001; 67 (4): 177.

11. Silva JA, Mesquita Kde C, Igreja AC, Lucas IC, Freitas AF, Oliveira SM et al. Paraneoplastic cutaneous manifestations: concepts and updates. An Bras Dermatol. 2013; 88 (1): 9-22.

12. Stollmeier A, Rosario BA, Mayer BL, Frandoloso GA, Magalhães FL, Marques GL. Seborrheic keratoses as the first sign of bladder carcinoma: case report of Leser-Trélat sign in a rare association with urinary tract cancer. Case Rep Med. 2016; 2016: 4259190.

13. Tajima H, Mitsuoka S, Ohtsuka E, Nakamura Y, Nakayama T, Satoh Y et al. A case of hepatocellular carcinoma with the sign of Leser-Trelat: a possible role of a cutaneous marker for internal malignancy. Jpn J Med. 1991; 30 (1): 53-56.

14. Patton T, Zirwas M, Nieland-Fisher N, Jukic D. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat. J Drugs Dermatol. 2004; 3 (5): 565-566.